Literature DB >> 29510423

Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth.

Erin A S Clark1, Steven J Weiner2, Dwight J Rouse3, Brian M Mercer4,5, Uma M Reddy6, Jay D Iams7, Ronald J Wapner8, Yoram Sorokin9, Fergal D Malone10, Mary J O'Sullivan11, Alan M Peaceman12, Gary D V Hankins13, Donald J Dudley14, Steve N Caritis15.   

Abstract

OBJECTIVE: To evaluate the association of magnesium sulfate (MgSO4) exposure and candidate gene polymorphisms with adverse neurodevelopmental outcomes following preterm birth. STUDY
DESIGN: We performed a nested case-control analysis of a randomized trial of maternal MgSO4 before anticipated preterm birth for the prevention of cerebral palsy (CP). Cases were children who died within 1 year of life or were survivors with abnormal neurodevelopment at age 2 years. Controls were race- and sex-matched survivors with normal neurodevelopment. We analyzed 45 candidate gene polymorphisms in inflammation, coagulation, and vascular regulation pathways and their association with (1) psychomotor delay, (2) mental delay, (3) CP, and (4) combined outcome of death/CP. Logistic regression analyses, conditional on maternal race and child sex, and adjusted for treatment group, gestational age at birth and maternal education, were performed.
RESULTS: Four hundred and six subjects, 211 cases and 195 controls, were analyzed. The strongest association was for IL6R (rs 4601580) in which each additional copy of the minor allele was associated with an increased risk of psychomotor delay (adjusted odds ratio 3.3; 95% confidence interval, 1.7-6.5; p < 0.001).
CONCLUSION: Candidate gene polymorphisms are associated with death and adverse neurodevelopmental outcomes following preterm birth. MgSO4 may abrogate this genotype association for some loci. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29510423      PMCID: PMC6129012          DOI: 10.1055/s-0038-1635109

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  35 in total

1.  Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.

Authors:  Maged M Costantine; Steven J Weiner
Journal:  Obstet Gynecol       Date:  2009-08       Impact factor: 7.661

2.  Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years.

Authors:  B H Yoon; R Romero; J S Park; C J Kim; S H Kim; J H Choi; T R Han
Journal:  Am J Obstet Gynecol       Date:  2000-03       Impact factor: 8.661

3.  The association of genetic polymorphisms with cerebral palsy: a meta-analysis.

Authors:  De Wu; Yan-Feng Zou; Xiao-Yan Xu; Xiao-Liang Feng; Li Yang; Gong-Chun Zhang; Xi-Song Bu; Jiu-Lai Tang
Journal:  Dev Med Child Neurol       Date:  2011-03       Impact factor: 5.449

4.  Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure.

Authors:  Catherine S Gibson; Alastair H MacLennan; Paul N Goldwater; Eric A Haan; Kevin Priest; Gustaaf A Dekker
Journal:  Am J Obstet Gynecol       Date:  2008-05       Impact factor: 8.661

5.  A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition.

Authors:  R Romero; R Gomez; F Ghezzi; B H Yoon; M Mazor; S S Edwin; S M Berry
Journal:  Am J Obstet Gynecol       Date:  1998-07       Impact factor: 8.661

6.  Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke.

Authors:  Alvaro Cervera; Anna M Planas; Carles Justicia; Xabier Urra; Jens C Jensenius; Ferran Torres; Francisco Lozano; Angel Chamorro
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

7.  Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants.

Authors:  Yvonne W Wu; Lisa A Croen; Anthony R Torres; Judy Van De Water; Judith K Grether; Nathaniel N Hsu
Journal:  Ann Neurol       Date:  2009-11       Impact factor: 10.422

8.  Genetic and clinical contributions to cerebral palsy: a multi-variable analysis.

Authors:  Michael E O'Callaghan; Alastair H Maclennan; Catherine S Gibson; Gai L McMichael; Eric A Haan; Jessica L Broadbent; Peter A Baghurst; Paul N Goldwater; Gustaaf A Dekker
Journal:  J Paediatr Child Health       Date:  2013-06-11       Impact factor: 1.954

9.  The association between inherited cytokine polymorphisms and cerebral palsy.

Authors:  Catherine S Gibson; Alastair H MacLennan; Paul N Goldwater; Eric A Haan; Kevin Priest; Gustaaf A Dekker
Journal:  Am J Obstet Gynecol       Date:  2006-03       Impact factor: 8.661

10.  A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.

Authors:  Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

View more
  4 in total

1.  Sex-Specific Genetic Susceptibility to Adverse Neurodevelopmental Outcome in Offspring of Pregnancies at Risk of Early Preterm Delivery.

Authors:  Michael W Varner; Maged M Costantine; Kathleen A Jablonski; Dwight J Rouse; Brian M Mercer; Kenneth J Leveno; Uma M Reddy; Catalin Buhimschi; Ronald J Wapner; Yoram Sorokin; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Mary J O'sullivan; Alan M Peaceman; Donald J Dudley; Steve N Caritis
Journal:  Am J Perinatol       Date:  2019-02-07       Impact factor: 1.862

2.  Genetic and epigenetic factors and early life inflammation as predictors of neurodevelopmental outcomes.

Authors:  Kirsi S Oldenburg; T Michael O'Shea; Rebecca C Fry
Journal:  Semin Fetal Neonatal Med       Date:  2020-05-15       Impact factor: 3.926

Review 3.  Glutamate Transport and Preterm Brain Injury.

Authors:  Silvia Pregnolato; Elavazhagan Chakkarapani; Anthony R Isles; Karen Luyt
Journal:  Front Physiol       Date:  2019-04-24       Impact factor: 4.566

Review 4.  Insights From Genetic Studies of Cerebral Palsy.

Authors:  Sara A Lewis; Sheetal Shetty; Bryce A Wilson; Aris J Huang; Sheng Chih Jin; Hayley Smithers-Sheedy; Michael C Fahey; Michael C Kruer
Journal:  Front Neurol       Date:  2021-01-21       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.